Angelalign Replaces European Feature After Patent Ruling
The company swapped a challenged orthodontic design for a new system following an unfavorable patent infringement decision.
Updated on Oct. 16, 2026 in Biotech
Live Poll
Do you believe patent litigation between medical device companies generally harms patient access to care?
The Paris Local Division of the Unified Patent Court has ruled that Angelalign Technology Inc. infringed on an Align Technology Inc. patent with its Torque Ridges feature. In response, Angelalign has discontinued the feature in the European market and replaced it with a new design.
Why it matters
The ruling forces a shift in product design for Angelalign in Europe, impacting how the company manages torque control for its orthodontic alignment systems. The move represents a significant regulatory hurdle for the company as it navigates intellectual property conflicts while maintaining its product capabilities.
Angelalign replaced the patented Torque Ridges feature with an upgraded system called Pressure Points. This new design is intended to improve torque control during orthodontic treatment, though specific mechanical performance benchmarks versus the retired feature remain unstated.
The players
Angelalign Technology Inc.
A publicly listed company with a US$2 billion market cap that provides orthodontic alignment systems across 60 countries.
Align Technology Inc.
The holder of the patent cited in the infringement ruling by the Unified Patent Court.
The details
The litigation centered on the Torque Ridges feature, an element of the company's clear aligner system used to apply force to teeth for complex movements. The replacement feature, Pressure Points, is designed to achieve similar clinical goals—specifically improving torque control and addressing complex orthodontic challenges—without utilizing the proprietary method protected by the Align Technology Inc. patent.
Timeline
2003: Angelalign Technology Inc. was founded.
2021: Angelalign Technology Inc. became publicly listed.
September 2026: The company launched Pressure Points in Europe.
October 16, 2026: The Unified Patent Court issued the ruling on patent infringement.
The Tech Race
The ruling marks a pivotal moment in the competitive landscape of the clear aligner market, as firms race to optimize tooth movement mechanics within strict IP boundaries. It forces Angelalign to pivot its European product strategy while its main competitors continue to advance their own proprietary treatment systems.
European orthodontists and patients will now see the new Pressure Points feature in place of Torque Ridges for all new treatments. Customers in the UK, Spain, the Americas, and Asia remain unaffected by this change and will continue to receive the standard product configurations.
The takeaway
The company's swift replacement of the contested feature with Pressure Points indicates a strategy to maintain operational continuity in Europe despite legal pressure. Watch for any subsequent disclosures regarding the financial impact of the feature transition in the next quarterly earnings report.
Further reading
For broader trends in medical device innovation and regulatory impacts, visit /tech/biotech/.
More information
For official updates from the company, visit the Angelalign company information site.
Live Poll
Do you believe patent litigation between medical device companies generally harms patient access to care?
